Morepen Laboratories VP Nishant Doshi Resigns
New Delhi: Morepen Laboratories Limited has announced the resignation of Nishant Jayesh Doshi, Vice President, Corporate Finance and Investor Relations, who has stepped down from his position as Senior Management Personnel to pursue a new professional opportunity, effective October 31, 2026.
Doshi tendered his resignation from Morepen Laboratories, with October 31, 2026, being his final working day after serving the requisite notice period.
In his resignation email addressed to the company's management, Doshi stated that he had decided to pursue a new professional opportunity that he considered more suitable for his career at this stage. He also expressed gratitude for the opportunities provided during his tenure and acknowledged the support received from the company's leadership team and colleagues.
Doshi further stated that he was proud of the achievements made during his association with Morepen Laboratories and wished the company and its employees continued success. He also expressed his intention to remain in touch with the team.
Also Read: Morepen Labs Baddi facility clears USFDA inspection without any adverse observation
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.